| 1 | Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Ng — 2017 | +0.056 | 4,514 |
| 2 | Ulcerative colitis. Ungaro — Lancet (London, England) · 2017 | -0.004 | 2,722 |
| 3 | Cancer treatment and survivorship statistics, 2022. Miller — CA: a cancer journal for clinicians · 2022 | +0.006 | 2,200 |
| 4 | British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Lamb — Gut · 2019 | -0.006 | 1,751 |
| 5 | Ulcerative colitis Ordás — Lancet · 2012 | +0.009 | 1,662 |
| 6 | Epidemiology and natural history of inflammatory bowel diseases. Cosnes — Gastroenterology · 2011 | +0.014 | 1,625 |
| 7 | The gut microbiota and host health: a new clinical frontier. Marchesi, Julian R — Gut · 2016 | +0.000 | 1,583 |
| 8 | Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Riddell — Human pathology · 1983 | +0.113 | 1,579 |
| 9 | Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. Giardiello — The New England journal of medicine · 1993 | +0.005 | 1,456 |
| 10 | Ulcerative colitis and colorectal cancer. A population-based study. Ekbom — The New England journal of medicine · 1990 | +0.046 | 1,432 |
| 11 | Cyclosporine in severe ulcerative colitis refractory to steroid therapy. Lichtiger — The New England journal of medicine · 1994 | +0.110 | 1,416 |
| 12 | Inflammatory bowel disease: clinical aspects and established and evolving therapies Baumgart — Lancet · 2007 | +0.004 | 1,414 |
| 13 | Microbial influences in inflammatory bowel diseases Sartor — Gastroenterology · 2008 | -0.010 | 1,410 |
| 14 | Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders Magro — J Crohns Colitis · 2017 | -0.011 | 1,372 |
| 15 | Ulcerative colitis Kobayashi — Nat Rev Dis Primers · 2020 | -0.005 | 1,240 |
| 16 | The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Greenstein — Medicine · 1976 | +0.099 | 1,060 |
| 17 | Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee Kornbluth — Am J Gastroenterol · 2010 | -0.009 | 1,027 |
| 18 | Ulcerative colitis. Le Berre Catherine — Lancet · 2023 | -0.001 | 1,024 |
| 19 | Proctocolectomy without ileostomy for ulcerative colitis. Parks A — Br Med J · 1978 | +0.400 | 1,023 |
| 20 | Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial Gionchetti — Gastroenterology · 2000 | -0.069 | 1,016 |
| 21 | Minimally invasive colon resection (laparoscopic colectomy). Jacobs — Surgical laparoscopy & endoscopy · 1991 | — | 973 |
| 22 | Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Frøslie — Gastroenterology · 2007 | +0.023 | 923 |
| 23 | Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Järnerot — Gastroenterology · 2005 | -0.059 | 821 |
| 24 | Guidelines for the management of inflammatory bowel disease in adults. Carter — Gut · 2004 | -0.003 | 786 |
| 25 | Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Madsen — Gastroenterology · 2001 | +0.000 | 761 |
| 26 | Reduced Paneth cell alpha-defensins in ileal Crohn's disease Wehkamp — Proc Natl Acad Sci U S A · 2005 | -0.018 | 761 |
| 27 | Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Colombel — Gastroenterology · 2011 | -0.031 | 752 |
| 28 | Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics Sartor — Gastroenterology · 2004 | -0.010 | 750 |
| 29 | Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults. Sodickson — Radiology · 2009 | -0.005 | 742 |
| 30 | Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. Ferlazzo — The Journal of experimental medicine · 2002 | -0.011 | 741 |
| 31 | Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial Gionchetti — Gastroenterology · 2003 | -0.067 | 740 |
| 32 | Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management Dignass — J Crohns Colitis · 2012 | -0.015 | 723 |
| 33 | Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Jess — Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2012 | -0.014 | 716 |
| 34 | Effects of gender, body composition, and menopause on plasma concentrations of leptin. Rosenbaum — The Journal of clinical endocrinology and metabolism · 1996 | -0.019 | 702 |
| 35 | Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. D'Haens — Gastroenterology · 1998 | +0.008 | 677 |
| 36 | Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells. Ménard — Journal of bacteriology · 1993 | +0.000 | 652 |
| 37 | Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy. Martin — Cell · 2019 | -0.001 | 645 |
| 38 | Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation Sinha — Cell Host Microbe · 2020 | -0.002 | 618 |
| 39 | Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Labayle — Gastroenterology · 1991 | -0.002 | 615 |
| 40 | Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches Sartor — Gastroenterology · 2017 | -0.004 | 612 |
| 41 | Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis Mimura — Gut · 2004 | -0.046 | 608 |
| 42 | European evidence based consensus for endoscopy in inflammatory bowel disease. Annese Vito — J Crohns Colitis · 2013 | -0.010 | 598 |
| 43 | Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Rutgeerts — Lancet (London, England) · 1991 | +0.060 | 594 |
| 44 | Predicting outcome in severe ulcerative colitis. Travis — Gut · 1996 | -0.035 | 591 |
| 45 | Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Solberg — Scandinavian journal of gastroenterology · 2009 | -0.016 | 576 |
| 46 | Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index Sandborn — Mayo Clin Proc · 1994 | -0.006 | 572 |
| 47 | Total colectomy, mucosal proctectomy, and ileoanal anastomosis. Utsunomiya — Dis Colon Rectum · 1980 | -0.091 | 570 |
| 48 | Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Winawer — Gastroenterology · 2006 | -0.016 | 553 |
| 49 | PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Loftus — Gut · 2005 | -0.010 | 546 |
| 50 | Prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, double-blind multicenter study Becker — J Am Coll Surg · 1996 | +0.026 | 543 |
| 51 | Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients Fazio — Ann Surg · 2013 | -0.066 | 529 |
| 52 | Course of ulcerative colitis: analysis of changes in disease activity over years. Langholz — Gastroenterology · 1994 | +0.142 | 523 |
| 53 | Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Turner — Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2007 | -0.008 | 493 |
| 54 | Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Kelly — The American journal of gastroenterology · 2014 | -0.027 | 487 |
| 55 | Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Laharie — Lancet (London, England) · 2012 | -0.014 | 483 |
| 56 | Visual motion processing and sensory-motor integration for smooth pursuit eye movements. — Annual review of neuroscience · 1987 | -0.019 | 481 |
| 57 | Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Rutter — Gastroenterology · 2006 | -0.048 | 479 |
| 58 | A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. Saxon — The Journal of allergy and clinical immunology · 1990 | -0.001 | 478 |
| 59 | Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee Kornbluth — Am J Gastroenterol · 2004 | -0.006 | 477 |
| 60 | Intra-abdominal "reservoir" in patients with permanent ileostomy. Preliminary observations on a procedure resulting in fecal "continence" in five ileostomy patients. Kock — Archives of surgery (Chicago, Ill. : 1960) · 1969 | +0.589 | 474 |
| 61 | Ulcerative Colitis in Adults: A Review. Gros — JAMA · 2023 | -0.000 | 463 |
| 62 | J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients Meagher — Br J Surg · 1998 | -0.034 | 460 |
| 63 | Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Schmitz — Gastroenterology · 1999 | +0.019 | 459 |
| 64 | Urinary diversion via a continent ileal reservoir: clinical results in 12 patients. Kock — The Journal of urology · 1982 | +0.058 | 457 |
| 65 | Intensive intravenous regimen for severe attacks of ulcerative colitis. Truelove — Lancet (London, England) · 1974 | -0.033 | 455 |
| 66 | Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Bernstein — Lancet (London, England) · 1994 | -0.067 | 450 |
| 67 | Cancer risk and life expectancy of children with ulcerative colitis. Devroede — The New England journal of medicine · 1971 | +0.023 | 447 |
| 68 | Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis. Seow — Gut · 2010 | -0.028 | 447 |
| 69 | Impact of Clostridium difficile on inflammatory bowel disease. Issa — Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2007 | +0.011 | 443 |
| 70 | Nerve-sparing robot-assisted radical cystoprostatectomy and urinary diversion. — BJU international · 2003 | +0.091 | 438 |
| 71 | Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study. van der Valk — Gut · 2014 | +0.019 | 436 |
| 72 | Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Vind — The American journal of gastroenterology · 2006 | -0.011 | 429 |
| 73 | Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Lutgens — Inflammatory bowel diseases · 2013 | -0.002 | 426 |
| 74 | Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease. Itzkowitz — Inflammatory bowel diseases · 2005 | -0.030 | 420 |
| 75 | Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Blackstone — Gastroenterology · 1981 | +0.207 | 412 |
| 76 | Familial adenomatous polyposis. Galiatsatos Polymnia — Am J Gastroenterol · 2006 | -0.005 | 412 |
| 77 | Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms. Olaison — Gut · 1992 | -0.062 | 410 |
| 78 | Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. Lloyd — Immunology today · 1992 | +0.013 | 405 |
| 79 | Familial adenomatous polyposis Half — Orphanet J Rare Dis · 2009 | -0.002 | 402 |
| 80 | Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis. Weismüller — Gastroenterology · 2017 | -0.037 | 399 |
| 81 | Review article: short chain fatty acids in health and disease Cook — Aliment Pharmacol Ther · 1998 | +0.034 | 396 |
| 82 | Colorectal cancer risk and mortality in patients with ulcerative colitis. Langholz — Gastroenterology · 1992 | -0.018 | 394 |
| 83 | Ileal pouch-anal anastomosis for chronic ulcerative colitis. Long-term results Pemberton — Ann Surg · 1987 | -0.023 | 394 |
| 84 | Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Ardizzone — Gut · 2006 | -0.019 | 388 |
| 85 | Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gillen — Gut · 1994 | -0.019 | 387 |
| 86 | Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Nugent K — Br J Surg · 1993 | -0.056 | 387 |
| 87 | Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Burak Kelly — Am J Gastroenterol · 2004 | -0.036 | 382 |
| 88 | Evidence-based clinical practice guidelines for inflammatory bowel disease Matsuoka — J Gastroenterol · 2018 | -0.000 | 381 |
| 89 | Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer. Landy, Jonathan — World journal of gastroenterology · 2016 | +0.000 | 379 |
| 90 | C-reactive protein as a marker for inflammatory bowel disease. Vermeire — Inflammatory bowel diseases · 2004 | +0.005 | 374 |
| 91 | Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Lennard-Jones — Gut · 1990 | -0.055 | 374 |
| 92 | Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis Penna — Gut · 1996 | -0.060 | 371 |
| 93 | Greater risk of incisional hernia with morbidly obese than steroid-dependent patients and low recurrence with prefascial polypropylene mesh Sugerman — Am J Surg · 1996 | -0.017 | 367 |
| 94 | Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Connell — Gastroenterology · 1994 | -0.079 | 364 |
| 95 | Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease. Hellers — Gut · 1980 | +0.292 | 362 |
| 96 | Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition Turner — J Pediatr Gastroenterol Nutr · 2018 | -0.005 | 362 |
| 97 | Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations Van Assche — J Crohns Colitis · 2013 | -0.004 | 359 |
| 98 | Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Brentnall — Gastroenterology · 1994 | -0.006 | 359 |
| 99 | Proctocolectomy with ileal reservoir and anal anastomosis Parks — Br J Surg · 1980 | -0.044 | 359 |
| 100 | Sulindac for polyposis of the colon. Waddell — American journal of surgery · 1989 | -0.009 | 357 |